Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

World

CNBC

WorldCNBC·Jun 8, 2026·1 min read

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

View original source — CNBC ↗

ShareShare on X Share on Facebook

Related stories

The Wegovy pill is still dominating the GLP-1 pill market

WorldJun 7, 2026 · 1 min

The Wegovy pill is still dominating the GLP-1 pill market

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Financial Times

HealthJun 8, 2026 · 1 min

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Financial Times

Three Questions About the Maine and South Carolina Primaries

The New York Times

WorldJun 8, 2026 · 1 min

Three Questions About the Maine and South Carolina Primaries

The New York Times

LIVE STREAM: Billam-Smith and Rozicki reignite rivalry at weigh-in!

WorldJun 5, 2026 · 1 min

LIVE STREAM: Billam-Smith and Rozicki reignite rivalry at weigh-in!